Literature DB >> 24117966

Rarely metastasizing soft tissue tumours.

D Chas Mangham1, Lars-Gunnar Kindblom.   

Abstract

Soft tissue tumours that rarely metastasize have been afforded their own subcategory in recent WHO classifications. This review discusses the nature of these tumours and the difficulty in constructing usefully simple classifications for heterogeneous and complex groups of tumours. We also highlight the specific rarely metastasizing soft tissue tumours that have been recently added to the WHO classification (phosphaturic mesenchymal tumour, pseudomyogenic haemangioendothelioma) and those entities where there have been recent important defining genetic discoveries (myxoinflammatory fibroblastic sarcoma, solitary fibrous tumour, myoepitheliomas).
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  GIST; PEComa; grade; intermediate; melanotic schwannoma; myoepithelioma; myxoinflammatory fibroblastic sarcoma; phosphaturic mesenchymal tumour; pseudomyogenic haemangioendothelioma; rarely metastasizing; sarcoma; solitary fibrous tumour

Mesh:

Year:  2013        PMID: 24117966     DOI: 10.1111/his.12310

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Primary pleural intermediate hemangioendothelioma with pleural effusion as the only manifestation.

Authors:  Juan Jiang; Yuanyuan Li; Chengping Hu; Jianhua Zhou; Huaping Yang; Liming Cao; Pengbo Deng
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 2.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

3.  Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.

Authors:  Meghan Higley; Brooke Beckett; Sandra Schmahmann; Elizabeth Dacey; Erik Foss
Journal:  Skeletal Radiol       Date:  2015-09-04       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.